Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Switch study of levothyroxine formulation after total or near-total thyroidectomy
2012-005732-28Phase 2Completed
- Sponsor
- Takeda
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of levothyroxine sodium in hypothyroidism, sponsored by Takeda. Primary endpoint: Proportion not requiring dose change after switch. Started Apr 2013; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on 2012-005732-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005732-28.